Clinical Trial Update: Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating oral azacitidine versus placebo as maintenance therapy after allogeneic stem cell transplantation in patients with acute mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Oral azacitidine (azacitidine (oral formulation))

Snippet

Sponsor: University of Birmingham | Conditions: Acute Myeloid Leukemia, Myelodysplasia | Phase 3 | Status: ACTIVE_NOT_RECRUITING